| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q4 2014 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| QUINCE THERAPEUTICS INC | 16 | Q3 2023 | 43.2% |
| ISHARES TR | 16 | Q3 2023 | 22.1% |
| ISHARES TR | 16 | Q3 2023 | 15.5% |
| VANGUARD INDEX FDS | 16 | Q3 2023 | 17.0% |
| SPDR GOLD TRUST | 16 | Q3 2023 | 8.4% |
| ALIBABA GROUP HLDG LTD | 16 | Q3 2023 | 8.0% |
| JD.COM INC | 16 | Q3 2023 | 3.3% |
| VANGUARD TAX-MANAGED INTL FD | 16 | Q3 2023 | 2.7% |
| VANGUARD INTL EQUITY INDEX F | 16 | Q3 2023 | 1.9% |
| SPDR S&P 500 ETF TR | 16 | Q3 2023 | 1.6% |
View EPIQ Capital Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Lucira Health, Inc.Sold out | December 22, 2022 | 0 | 0.0% |
View EPIQ Capital Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-09 |
| SC 13D/A | 2024-01-05 |
| 4 | 2023-12-29 |
| 13F-HR | 2023-11-08 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-11 |
| 13F-HR/A | 2023-02-14 |
| 13F-HR | 2023-02-13 |
| SC 13D/A | 2022-12-22 |
| 4 | 2022-12-16 |
View EPIQ Capital Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.